<DOC>
	<DOCNO>NCT02106832</DOCNO>
	<brief_summary>The purpose study evaluate time first pulmonary exacerbation bronchiectasis frequency prolong inhalation ciprofloxacin 28 day every 28 day 14 day every 14 day 48 week .</brief_summary>
	<brief_title>Ciprofloxacin Dry Powder Inhalation ( DPI ) Non-cystic Fibrosis Bronchiectasis ( Non-CF BE )</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Patients proven document diagnosis non CF idiopathic post infectious bronchiectasis Stable pulmonary status stable regimen standard treatment least past 4 week Forced expiratory volume 1 second ( FEV1 ) &lt; 30 % &gt; 90 % predict Active allergic bronchopulmonary aspergillosis Active actively treat non tuberculosis mycobacterial ( NTM ) infection tuberculosis Primary diagnosis Chronic obstructive pulmonary disease ( COPD )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Ciprofloxacin</keyword>
	<keyword>Dry Powder Inhalation</keyword>
	<keyword>Exacerbation</keyword>
	<keyword>Bronchiectasis</keyword>
</DOC>